INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 16, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,921 | -- | -- |
| Dec 16, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 146,815 | -- | 146,815 |
| Dec 04, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,654 |
| Nov 16, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 1,612 | -- | 567,976 |
| Nov 03, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,654 |
| Nov 03, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 569,588 |
| Nov 02, 2015 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 43,348 | -- | 500,000 |
| Nov 02, 2015 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 43,348 | -- | 612,936 |
| Oct 30, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 182,818 | -- | -- |
| Dec 18, 2014 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,623 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.